Palisade Bio (PALI) Exchange Rate Effect (2013 - 2021)
Palisade Bio (PALI) posted quarterly Exchange Rate Effect of -$1042.0 for Q1 2021, down 50.58% year-over-year from -$2108.4 in Q1 2020, and up 65.21% quarter-over-quarter from -$2995.0 in Q4 2020.
Palisade Bio (PALI) Exchange Rate Effect (2013 - 2021) Analysis & Trends
Palisade Bio (PALI) has reported Exchange Rate Effect for 9 consecutive years, with -$1042.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Exchange Rate Effect fell 50.58% year-over-year to -$1042.0; the TTM figure through Mar 2021 stood at -$1535.0 (up 79.84% YoY), while the FY2020 annual figure was -$1185.0, up 80.31% from the prior year.
- Exchange Rate Effect grew to -$1042.0 in Q1 2021 per PALI's latest filing, from -$2995.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2639.0 in Q3 2020 and bottomed at -$6443.0 in Q3 2019.
- Historically, Exchange Rate Effect has averaged -$985.53 across 5 years, with a median of -$692.0 in 2020.
- On a YoY basis, Exchange Rate Effect climbed as much as 372.28% in 2018 and fell as far as 1320.11% in 2018.
- Palisade Bio's Exchange Rate Effect stood at $816.0 in 2017, then sank by 412.13% to -$2547.0 in 2018, then soared by 129.05% to $740.0 in 2019, then slumped by 504.73% to -$2995.0 in 2020, then soared by 65.21% to -$1042.0 in 2021.
- Business Quant data shows PALI's Exchange Rate Effect at -$1042.0 in Q1 2021, -$2995.0 in Q4 2020, and $2639.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -1,042.00 |
| Mar 31, 2021 | -1,042.00 |
| Dec 31, 2020 | -2,995.00 |
| Dec 31, 2020 | -2,995.00 |
| Sep 30, 2020 | 2,639.00 |
| Sep 30, 2020 | 2,639.00 |
| Jun 30, 2020 | -137.00 |
| Jun 30, 2020 | -137.00 |
| Mar 31, 2020 | -692.00 |
| Mar 31, 2020 | -692.00 |
| Dec 31, 2019 | 740.00 |
| Dec 31, 2019 | 740.00 |
| Sep 30, 2019 | -6,443.00 |
| Sep 30, 2019 | -6,443.00 |
| Jun 30, 2019 | -1,218.00 |
| Jun 30, 2019 | -1,218.00 |
| Mar 31, 2019 | 903.00 |
| Mar 31, 2019 | 903.00 |
| Dec 31, 2018 | -2,547.00 |
| Dec 31, 2018 | -2,547.00 |